Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at hig
about
Rationale and design of the Children's Oncology Group (COG) study ALTE1621: a randomized, placebo-controlled trial to determine if low-dose carvedilol can prevent anthracycline-related left ventricular remodeling in childhood cancer survivors at hig
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Rationale and design of the Ch ...... ldhood cancer survivors at hig
@ast
Rationale and design of the Ch ...... ldhood cancer survivors at hig
@en
type
label
Rationale and design of the Ch ...... ldhood cancer survivors at hig
@ast
Rationale and design of the Ch ...... ldhood cancer survivors at hig
@en
prefLabel
Rationale and design of the Ch ...... ldhood cancer survivors at hig
@ast
Rationale and design of the Ch ...... ldhood cancer survivors at hig
@en
P2093
P2860
P1476
Rationale and design of the Ch ...... ldhood cancer survivors at hig
@en
P2093
Aida Siyahian
Daniel M Green
F Lennie Wong
George Mills
Lanie Lindenfeld
Leslie L Robison
Melissa M Hudson
Ming Hui Chen
Sarah Gelehrter
P2860
P2888
P356
10.1186/S12872-016-0364-6
P577
2016-10-04T00:00:00Z
P6179
1006045741